Inquiry Basket
Loading ......
Filter By Product Search for
s. pneumoniae cwps
S. pneumoniae CWPS Full Name
Streptococcus pneumoniae CWPS
S. pneumoniae CWPS Introduction
Streptococcus pneumoniae is a Gram-positive, lancet-shaped diplococcus that represents one of the most clinically significant human pathogens, responsible for substantial morbidity and mortality worldwide through diseases including community-acquired pneumonia, bacterial meningitis, otitis media, and invasive bloodstream infections. The cell wall of S. pneumoniae contains two major polysaccharide components: the serotype-specific capsular polysaccharide (CPS) that forms the outermost layer and the cell wall polysaccharide (CWPS), also known as C-polysaccharide or teichoic acid, which is embedded within the peptidoglycan matrix and is structurally conserved across all pneumococcal serotypes. The CWPS is characterized by the presence of phosphorylcholine (ChoP) residues, which serve as anchoring sites for a family of surface proteins known as choline-binding proteins (CBPs), including the major autolysin LytA, the adhesin CbpA, and the pore-forming toxin pneumolysin-related proteins. This phosphorylcholine moiety is immunologically significant, as it was through the interaction between CWPS and a serum protein that C-reactive protein (CRP) was originally discovered, establishing the foundation for understanding acute-phase responses in human disease. The conservation of CWPS across all pneumococcal serotypes distinguishes it fundamentally from the capsular polysaccharide, which exhibits remarkable structural diversity with over 100 serotypes currently recognized, each with distinct immunological properties.
The biological functions of CWPS extend beyond structural roles to encompass critical aspects of pneumococcal physiology, pathogenesis, and host-pathogen interactions. The phosphorylcholine residues within CWPS interact with platelet-activating factor receptor (PAFr) on host epithelial and endothelial cells, facilitating bacterial adhesion, invasion, and translocation across tissue barriers, including the blood-brain barrier during the development of meningitis. This molecular mimicry, whereby bacterial phosphorylcholine resembles the phosphorylcholine head group of platelet-activating factor, represents a sophisticated virulence strategy that enables pneumococci to exploit host cell signaling pathways for invasion. Additionally, CWPS-associated teichoic acids contribute to the structural integrity of the pneumococcal cell wall, influence susceptibility to autolysis mediated by LytA, and affect the activity of cell wall-targeting antibiotics such as beta-lactams and vancomycin. The choline-binding proteins anchored to CWPS participate in diverse functions including cell division, daughter cell separation, biofilm formation, and immune evasion through binding of complement regulators and immunoglobulins. Understanding the structure-function relationships of CWPS has revealed potential vulnerabilities that could be exploited for therapeutic intervention, including the development of small molecules that interfere with choline-binding protein attachment or antibodies that target conserved CWPS epitopes.
The conserved nature of CWPS has generated considerable interest in its potential applications for serotype-independent pneumococcal diagnostics and vaccine development. Current pneumococcal conjugate vaccines (PCVs) target a limited number of capsular serotypes, and while highly effective against vaccine serotypes, they have led to serotype replacement whereby non-vaccine serotypes emerge to fill the ecological niche. A vaccine incorporating CWPS or CWPS-derived antigens could theoretically provide protection against all pneumococcal serotypes, addressing the fundamental limitation of capsule-based vaccines. Diagnostic applications of CWPS detection include urinary antigen tests that identify pneumococcal infection regardless of serotype, providing rapid point-of-care diagnosis in clinical settings. Research into CWPS has also revealed its role in natural immunity, as antibodies against phosphorylcholine and other CWPS epitopes are present in human sera and may contribute to age-related changes in susceptibility to pneumococcal disease. The teichoic acid biosynthesis pathway represents another potential target for novel antimicrobial agents, as inhibition of this pathway could compromise cell wall integrity and enhance susceptibility to host defenses and existing antibiotics. Continued investigation of CWPS biology, immunology, and biosynthesis will inform the development of next-generation pneumococcal vaccines and therapeutics that overcome the limitations of current serotype-specific approaches.
Alternate Names for S. pneumoniae CWPS
Streptococcus pneumoniae; S. pneumoniae; Firmicutes; bacilli; Lactobacillales; Streptococcaceae; Streptococcus; S. pneumoniae CWPS; Streptococcus pneumoniae Cell Wall Polysaccharide; CWPS; Cell Wall Polysaccharide
Loading ......
